Current Chapter Reviews


Current work plan of chapter reviews:

Each chapter, with the exception of Chapter 5 Infections (antibacterial section), is scheduled for review every two years. Although it is acknowledged that this is often not possible and the review period may be extened.

Changes to a chapter may occasionally become necessary between reviews, for example, when the Drugs and Therapeutics Committee (DTC) approve new therapies, or a drug is withdrawn from supply. These changes will be made, within 3 months of the Joint Formulary Committee agreement, on the web-based version of the formulary.

Estimated/provisional guide time for review consultation & working groupChapter Progress 
May/June 2011Chapter 11, EyeReview comments with Consultant - Delayed
March 2012 (Pain section only) 
Chapter 4, Central nervous system (part 2)
Completed
April 2012 (Epilepsy section only) 
Review with Consultant 
September 2012
Chapter 2, Cardiovascular system
Statins only
October/November 2012
Chapter 12, Ear, nose and oropharynx
Combined review with SDJF 
October 2012 Chapter 10, Musculoskeletal and joint diseases Review comments asked for
October/November 2012
Chapter 5, Infections (antibacterials only) 
With Microbiology
 Chapter 7, Obstetrics, gynaecology and urinary-tract disorders
 
 Chapter 1, Gastrointestinal system
 
 Chapter 4, Central nervous system (part 1 Mental Health)
 
 Chapter 9, Nutrition and blood
 
 Chapter 3, Respiratory System 
 Chapter 14, Immunological products and vaccines
 
 Chapter 16, Palliative care
 
 Chapter 6, Endocrine system
 
 Chapter 13, Skin
 
 Chapter 5, Infections 
 

Last updated by: Carol Webb on 01-10-2012 09:53